Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Chembio Diagnostics (NQ: CEMI )

3.870 USD -0.020 (-0.51%)
Official Closing Price Updated: 7:57 PM EDT, Apr 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Chembio Diagnostics

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Thinking about buying stock in Nano-X Imaging, Chembio Diagnostics, Leaf Group, DMY Technology, or Cidara Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for NNOX, CEMI, LEAF, DMYD, and CDTX. 
From PR Newswire
Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu
In-licensed Rapid Point-of-Care Test Available for Use in Detecting COVID-19 Antigens, Flu A and Flu B from a Single Patient Sample in 15 Minutes 
From GlobeNewswire News Releases
Chembio Diagnostics Reports Fourth Quarter and Full Year 2020 Financial Results
From GlobeNewswire News Releases
Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors
From GlobeNewswire News Releases
Chembio Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021
From GlobeNewswire News Releases
Thinking about buying stock in Express, Nantkwest, Gevo, Canopy Growth Corp, or Chembio Diagnostics?
InvestorsObserver issues critical PriceWatch Alerts for EXPR, NK, GEVO, CGC, and CEMI. 
From PR Newswire
Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems
Enters Exclusive U.K. and Ireland Distribution Agreement with Luas Diagnostics 
From GlobeNewswire News Releases
Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors
From GlobeNewswire News Releases
Innovations in Disinfection Technology Aid the Return of Workers
FinancialBuzz.com News Commentary 
From PR Newswire
Comprehensive Diagnostics Remains a Priority As More Surges are Expected
- FinancialBuzz.com News Commentary 
From PR Newswire
Chembio Diagnostics Awarded $12.7 Million by BARDA for Development of Rapid DPP Respiratory Antigen Panel and 510(k) Submission of the Rapid DPP SARS-CoV-2 Antigen Test System
From GlobeNewswire News Releases
The Need for Precise Testing Capabilities is Clear as Cases Surge
FinancialBuzz.com News Commentary 
From PR Newswire
Chembio Diagnostics Receives ANVISA Approval for DPP SARS-CoV-2 Antigen Test System in Brazil
From GlobeNewswire News Releases
Chembio Diagnostics Reports Third Quarter 2020 Financial Results
From GlobeNewswire News Releases
New Disinfection Technology and Wide Range of PPEs Emerge at a Time of Need
FinancialBuzz.com News Commentary 
From PR Newswire
Chembio Diagnostics to Report Third Quarter 2020 Financial Results on November 5, 2020
From GlobeNewswire News Releases
NASDAQ:CEMI Long Term Investor Notice: Investigation over Possible Wrongdoing at Chembio Diagnostics, Inc.
San Diego, CA -- (SBWIRE) -- 10/21/2020 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Chembio Diagnostics, Inc. 
From SBWire - Latest Press Releases
Chembio Diagnostics Submits EUA Application for DPP SARS-CoV-2 Antigen Test System
Rapid Test Provides Results in Only 20 Minutes 
From GlobeNewswire News Releases
More Stringent Testing is Planned in a Bid to Return to Normalcy
FinancialBuzz.com News Commentary 
From PR Newswire
Chembio Diagnostics Receives FDA Approval for DPP HIV-Syphilis System
First Rapid Test Approved in U.S. to Aid in Diagnosis of Both HIV and Syphilis from Single Patient Sample 
From GlobeNewswire News Releases
Chembio Submits EUA Application for New DPP SARS-CoV-2 IgM/IgG Test System
New Antibody Test System Provides Results in 15 Minutes from Finger Stick, Venous Whole Blood, Plasma, or Serum Samples 
From GlobeNewswire News Releases
CLASS ACTION UPDATE for ENPH, CEMI and BKD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
From ACCESSWIRE
CLASS ACTION UPDATE for CEMI, BKD and AGS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
From ACCESSWIRE
SHAREHOLDER ALERT: ENPH CEMI CODX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
From ACCESSWIRE
CEMI FINAL DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Reminds Chembio Diagnostics, Inc. Investors of Important August 17 Deadline in Securities Class Action – CEMI
From GlobeNewswire News Releases
SHAREHOLDER ALERT: PRA ENPH CEMI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
From ACCESSWIRE
CLASS ACTION UPDATE for CEMI, KL and JCOM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
From ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Chembio Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline – CEMI
From GlobeNewswire News Releases
SHAREHOLDER ALERT: CEMI CODX KL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
From ACCESSWIRE
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Chembio Diagnostics, Inc. (CEMI)
The Law Offices of Frank R. Cruz reminds investors of the upcoming August 17, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Chembio... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.